Philadelphia-based bioprinting company Allevi was founded in 2014, then known as BioBots. Its goal is to make bioprinting easy – no small task, as bioprinting has always been a complex, advanced procedure. But Allevi’s desktop bioprinters are designed to be easy to use and versatile, while remaining powerful. Allevi has grown into a global company with customers in labs all over the world, and its bioprinters and bioinks have been used in some groundbreaking research.
Allevi is now introducing its latest 3D printer, the Allevi 3, which joins the Allevi 1, Allevi 2 and Allevi 6 – as well as the Allevi ZeroG, the first 3D bioprinter in space. According to the company, the Allevi 3 allows users to “print any cell line, into any geometry for any application that you can imagine.” Like Allevi’s other 3D bioprinters, the Allevi 3 is designed to be easy to use, a plug-and-play machine with pre-made protocols for all bioinks and easy-to-follow tutorials available. Allevi also offers plenty of support to help customers with any needs or issues they may have.
Versatility is another feature the Allevi 3 boasts. Each extruder has a full temperature range from 4°C to 160ºC, and users can control every print parameter using Allevi software. It also features an open platform for full customization possibilities. The printer is capable of 3D printing with any material, ranging from collagen to thermoplastics. Other possibilities include matrigel solutions, alginate, graphene, carbohydrate glass and more.
The Allevi 3 has three extruders, hence its name, allowing users to fabricate complex tissues in one simple step. The print bed features temperature control from RT-60C to keep cells viable for longer periods, as well as to hold petri dishes, well plates and glass slides. The printer offers auto calibration, making it even easier to use, and users can choose to cure their bioinks in either visible or ultraviolet light. The extruders have two separate LEDs in the ranges of 365nm and 405nm, and light intensity can be adjusted from 0 to 20 mW/cm2.
The 3D bioprinter’s extruders and bed plate are interchangeable to make the machine future-proof, allowing it to evolve with changes in bioprinting technology. The system is completely open – it accepts 5mL luer lock syringes and is compatible with every bioink kit that Allevi offers on its platform.
A few specifications of the Allevi 3:
- Dimensions: 16 x 14 x 14 in
- Weight: 22 lbs
- XY precision: 1 micron
- Z precision: 1 micron
- Print resolution: 150 microns
- Build volume: 9 x 13 x 6 mm
According to Allevi, the new 3D printer was inspired by the work of the company’s customers around the world. Allevi takes obvious pride in the advances that its clients have made with the use of its bioprinters, and states that “We believe everyone has the potential to change the course of medicine.” There are numerous bioprinting companies in the world, and while that makes for some stiff competition, one could argue that the more companies there are, the better, as scientists work toward eliminating the organ donor waiting list, creating new pharmaceuticals and disease treatments, and more. Who knows what might be accomplished with the Allevi 3?
Discuss this and other 3D printing topics at 3DPrintBoard.com or share your thoughts below.
[Images: Allevi]
Subscribe to Our Email Newsletter
Stay up-to-date on all the latest news from the 3D printing industry and receive information and offers from third party vendors.
You May Also Like
Divide by Zero Releases $500 Altron 3D Printer with Advanced Features
Indian original equipment manufacturer (OEM) Divide by Zero Technologies has released its latest 3D printer, the Altron. Priced at $500, the machine features spaghetti detection, automatic calibration, nozzle height detection,...
3D Printing News Briefs, September 12, 2024: Scholarships, Pool Maintenance, Shoes, & More
In 3D Printing News Briefs today, four graduate students received $10,000 scholarships from ASTM International, and 3DPRINTUK announced the first commercial launch of the Stratasys SAF printer in the UK....
Stratasys vs. Bambu Lab: A 3D Printing Patent Dispute with Far-Reaching Implications
Additive manufacturing (AM) stalwart Stratasys Ltd. (Nasdaq: SSYS) has initiated legal action against Bambu Lab and its associated entities, alleging patent infringement by their 3D printers. Filed in the US...
Regular, Medium, and Large Format 3D Printing Explained
At Additive Manufacturing (AM) Research and on 3DPrint.com, we use the terms regular, medium, and large format to segment the 3D printing market. We developed these terms to help bring...